Enveda Secures $130 Million in Funding to Revolutionize Drug Discovery with AI Technology

Enveda, a promising startup in the realm of artificial intelligence-driven drug discovery, has successfully raised an impressive $130 million in its latest funding round. This substantial investment reflects growing confidence in the potential of AI capabilities to transform traditional pharmaceutical practices by significantly accelerating the process of discovering and developing new drugs.

Continue reading